α-Synuclein (aSyn) toxicity is associated with cell cycle alterations, activation of DNA damage responses (DDR), and deregulation of autophagy. However, the relationships between these phenomena remain largely unknown. Here, we demonstrate that in a yeast model of aSyn toxicity and aging, aSyn expression induces Ras2-dependent growth signaling, cell cycle re-entry, DDR activation, autophagy, and autophagic degradation of ribonucleotide reductase 1 (Rnr1), a protein required for the activity of ribonucleotide reductase and dNTP synthesis. These events lead to cell death and aging, which are abrogated by deleting RAS2, inhibiting DDR or autophagy, or overexpressing RNR1. aSyn expression in human H4 neuroglioma cells also induces cell cycle re-entry and S-phase arrest, autophagy, and degradation of RRM1, the human homologue of RNR1, and inhibiting autophagic degradation of RRM1 rescues cells from cell death. Our findings represent a model for aSyn toxicity that has important implications for understanding synucleinopathies and other age-related neurodegenerative diseases.
| INTRODUCTION
α-Synuclein (aSyn) is a presynaptic neuronal protein that is genetically and neuropathologically linked to a group of age-related neurodegenerative diseases called synucleinopathies. The abnormal accumulation of aSyn aggregates is characteristic of this group of disorders that includes, among others, Parkinson's disease (PD). aSyn has been implicated in diverse physiological processes including the regulation of calcium and mitochondrial homeostasis, polyunsaturated fatty acids levels, and chaperone activity (Wales, Pinho, Lazaro, & Outeiro, 2013) . However, the normal physiological functions of aSyn as well as the nature of the cytopathic effects of aSyn overexpression and mutations remain incompletely understood. An emerging body of evidence suggests that cell cycle aberrations, including inappropriate re-entry into the cell cycle, are linked to the pathological effects of aSyn (Sharma et al., 2017; Tokarz, Kaarniranta, & Blasiak, 2016) . For example, elevated levels of proteins involved in cell cycle re-entry and DNA synthesis in dopaminergic neurons are observed in the brain of PD patients (Hoglinger et al., 2007) . Cell cycle re-entry, DNA damage, activation of DNA damage responses (DDR), and cell death have also been observed in numerous cellular and animal models of PD and other synucleinopathies (Camins et al., 2010; Lee et al., 2003; Paiva et al., 2017; Smith et al., 2003) . Furthermore, inhibition of cyclin-dependent kinases (Cdks) can induce neuroprotective effects (Rideout, Wang, Park, & Stefanis, 2003) .
Together, evidence from studies of humans as well as from experimental models strongly suggests a role for cell cycle re-entry and DDR in the mechanisms of aSyn pathobiology.
Mounting evidence suggests that macroautophagy (hereafter autophagy), a self-degradation pathway, plays a key role in the DDR by controlling the levels of proteins involved in cell cycle checkpoints and DNA synthesis/repair mechanisms. Particularly relevant is the discovery that in the model organism Saccharomyces cerevisiae (budding yeast), DNA damage induces the autophagic degradation of ribonucleotide reductase 1 (Rnr1) (Dyavaiah, Rooney, Chittur, Lin, & Begley, 2011) , which is the large subunit of ribonucleotide reductase (RNR), a highly conserved enzyme that catalyzes the formation of deoxyribonucleotides required for both DNA replication and repair.
In budding yeast, DDR was also found to activate a selective pathway of autophagy, termed genotoxin-induced targeted autophagy (GTA), which requires the involvement of the Mec1 and Rad53 kinases, as well as a central component of the selective autophagy machinery, Atg11 (Eapen et al., 2017) . Also relevant here is the recent discovery that Mec1 plays a fundamentally important role in protein homeostasis (Corcoles-Saez et al., 2018) .
Budding yeast has been extensively employed in models of PD and other synucleinopathies (Tenreiro, Franssens, Winderickx, & Outeiro, 2017) . Previously, we showed in the budding yeast chronological aging model that aSyn toxicity is associated with the enhanced autophagy that depends on Atg11 (Sampaio-Marques et al., 2012) . Here, we show that in quiescent stationary-phase budding yeast cells, which mimic the quiescent state of postmitotic neurons, aSyn expression promotes cell cycle re-entry, S-phase arrest, and DDR activation. The induction of DDR is responsible for a dramatic increase in autophagy, which in turn causes the degradation of Rnr1 and cell death that leads to premature aging in the budding yeast chronological aging model. Expression of aSyn in human H4 neuroglioma cells also induces the accumulation of cells in S-phase, autophagy and the degradation of RRM1, the human homologue of Rnr1, and cell death, which is blocked by inhibiting autophagy. These findings reveal a novel mechanism for aSyn toxicity in aged postmitotic cells that involves the inappropriate entry of cells into S-phase followed by DDR and the autophagy-dependent loss of RNR activity.
| RESULTS

| aSyn toxicity in budding yeast cells is
associated with cell cycle re-entry, S-phase arrest, and increased autophagy aSyn promotes autophagy and mitochondrial dysfunction; however, the relationship between metabolic stress, autophagy, DNA damage responses (DDR), and cell death induced by aSyn remains poorly understood. To learn more about these phenomena and how they might be related to re-entry of quiescent cells into the cell cycle, wt aSyn (aSyn) or the PD-associated mutant A30P aSyn, which is not toxic in budding yeast cells (Outeiro & Lindquist, 2003) , was constitutively expressed in wild-type yeast cells. (Figure 1f ). Re-entry of quiescent cells into the cell cycle was also indicated by an increased bud index detected in cells expressing aSyn ( Figure 1g ). An increased percentage of aSyn-expressing cells with a DNA content less than G0/G1 (Figure 1f ) was also observed, consistent with the previously described aSyn-induced apoptotic cell death (Flower, Chesnokova, Froelich, Dixon, & Witt, 2005) and with the survival data presented in Figure 1a .
Cyclin Cln3, required for the G1-to-S transition, was increased at both the mRNA and protein level in cells expressing aSyn in comparison with cells expressing the nontoxic A30P aSyn variant or the vector control (Figure 1h-j) . Our results also showed that CLN3 deletion abrogates aSyn toxicity as observed by the overlapped CLS curves associated with an autophagy flux similar to cells expressing the nontoxic A30P aSyn variant or the vector control, and decreased percentage of cells in S-phase (Figure 1k-o) . To support the crucial role of Cln3 in the transition from G1 phase to S-phase, the expression levels of CLN1 and CLN2, which assist Cln3 in this transition, and of the S-phase cyclins CLB5 and CLB6, were evaluated. The results revealed a significant increased expression of all of these cyclins in aSyn-expressing cells during CLS (Supporting information Figure S2 ). Notably, aSyn toxicity is dependent on the molecular chaperone Ydj1, which mediates the release of Cln3 from the ER, its nuclear accumulation, and cell cycle entry (Verges, Colomina, Gari, Gallego, & Aldea, 2007 ) (Supporting information Figure S2 ). These results unequivocally prove that aSyn causes cells to re-enter the cell cycle. They establish a previously unknown relationship between aSyn toxicity, enhanced autophagy, cell cycle re-entry, and S-phase arrest in aged budding yeast cells, phenomena that are independent of yeast strain background (Supporting information Figure S3 ).
| Abrogation of Ras2 signaling abolishes aSyn
toxicity by inducing a G0/G1 arrest, inhibition of DNA damage responses, and autophagy
In budding yeast, abrogation of RAS2, a gene encoding a member of a family of small GTPases conserved in humans, is known to induce an efficient G0/G1 arrest in stationary phase that protects cells against DNA replication stress and damage (Weinberger et al., 2007) . 
| Autophagy-dependent degradation of Rnr1 is a proximate cause of aSyn toxicity in budding yeast cells
In budding yeast, ribonucleotide reductase 1 (Rnr1), which is the large subunit of RNR, an enzyme that maintains dNTP pools required for DNA synthesis and repair, is degraded by autophagy (Dyavaiah et al., 2011) . We next asked whether S-phase arrest in cells express- To determine whether the reduction in levels of Rnr1 is caused by DDR-dependent autophagy, autophagy was pharmacologically inhibited by chloroquine (CQ), which increases vacuolar pH and inhibits vacuole-autophagosome fusion (Lenz & Holzer, 1984 
| DISCUSSION
Inappropriate re-entry into the cell cycle of postmitotic neurons followed by the death of these cells is frequently observed in PD and other synucleinopathies (Folch et al., 2012; Lee et al., 2003;  F I G U R E 5 aSyn promotes S-phase cell cycle arrest, increases autophagy, and decreases RRM1 levels in human cells. To our knowledge, our data provide the first evidence that the aSyninduced re-entry into the cell cycle detected in PD and other synucleinopathies can be recapitulated in the model organism budding yeast. This should facilitate the molecular dissection of this specific phenotype using the powerful genetics and other tools available in the model organism budding yeast.
In addition, inhibition of cell cycle re-entry of budding yeast cells expressing aSyn by forcing these cells to arrest the cell cycle at G0/ G1 phase by RAS2 or RIM15 deletion (Figure 2 ) or caloric restriction (Guedes et al., 2016) , as well as abrogation of DDR by genetic ablation of the MEC1 kinase, protects against aSyn-mediated toxicity, resulting in an extended CLS. Interestingly, aSyn expression in rat PC12 cells also induces RAS signaling in concert with the accumulation of cells in S-phase (Lee et al., 2003) , which suggests that growth signaling by RAS-dependent pathways is a conserved feature of this phenotype of synucleinopathies. Together, these findings support an active role of RAS-dependent cell cycle re-entry and DDR in promoting the toxic effects of expressing aSyn in quiescent yeast cells and by extension in postmitotic mammalian neurons. This is consistent with emerging models of the toxic effects of cell cycle re-entry in synucleinopathies and other neurodegenerative disorders (Sharma et al., 2017; Tokarz et al., 2016) . Postmitotic cells may enter the cell cycle in response to stress signals induced by the accumulation of toxic forms of aSyn, perhaps as part of an aborted attempt to replace dying cells.
Our previously reported data (Sampaio-Marques et al., 2012) and results presented here establish that autophagy, which is a fundamentally important pro-survival mechanism, has deleterious effects on aged cells expressing aSyn. A pro-death role for a survival pathway is apparently contradictory. However, although increased autophagic flux likely mediates aSyn clearance in functionally competent cells, it might also affect autophagy efficiency and selectivity in aged cells (Chu, 2011) that have a reduced ability to simultaneously upregulate anabolic processes.
The results presented here indicate that the induction of DDR associated with the inappropriate entry into S-phase of budding yeast cells in response to Ras2-dependent growth signaling underlies the induction of autophagy that, in turn, leads to a reduction in levels of Rnr1 (Figure 6 ). This likely causes cells to remain trapped in S-phase and triggers regulated cell death. Our data also demonstrate that cell death induced by expression of aSyn in budding yeast can be inhibited by overexpression of RNR1 or by inhibition of DDR or autophagy. Thus, inappropriate re-entry into S-phase that induces DDR and autophagy upstream of the autophagic reduction in levels of Rnr1 is a proximate cause of aSyn toxicity in yeast (Figure 6 ).
Interestingly, a connection between aSyn expression and regulation of Rnr1 levels in budding yeast was previously reported (Liu et al., 2011) . However, in this earlier study, in contrast to the effects of toxic levels of aSyn expression in our study, low, nontoxic levels of aSyn increased, rather than decreased, levels of Rnr1. Together with our findings, these data point to a normal function of aSyn that involves upregulation of RNR to maintain genome stability, perhaps by promoting DNA replication and homologous recombinational repair of DNA damage when it occurs in quiescent cells, which is superseded by a switch to inhibition of RNR activity that induces cell death in cells expressing toxic levels of aSyn.
The proposed targeted mechanism of autophagy activation by DDR (Eapen et al., 2017) seems to be operational in the context of aSyn toxicity during chronological aging. In fact, we have previously shown that autophagy-mediated aSyn-induced premature aging is dependent on Atg11 (Sampaio-Marques et al., 2012), which is also required for the genotoxin-targeted autophagy (GTA) pathway (Eapen et al., 2017) . Our previous data also demonstrated that autophagy induction and aSyn toxicity are dependent on sirtuin 2 (Sir2) (Sampaio-Marques et al., 2012) . Thus, a key question is as follows: How is autophagy dependent on DDR and/or Sir2?
The role of sirtuins on genomic stability associated with the regulation of chromatin dynamics and protection of DNA from damage by modulation of DNA repair mechanisms is well known. Interestingly, aSyn has been shown to inhibit the activity of histone acetyltransferase (HAT) enzymes, thus deregulating the dynamic control of gene transcription (Kontopoulos, Parvin, & Feany, 2006) . The relevance of sirtuins to neurodegeneration was recently highlighted in a report showing that SIRT2 modulates proteotoxicity associated with age-related neurodegenerative disorders such as PD (de Oliveira et al., 2017) . In yeast, in response to DNA damage, Sir2 is recruited by DDR via Mec1 and relocalizes to sites of DNA breakage (Mills, Sinclair, & Guarente, 1999) . This suggests the interesting hypothesis that Sir2 might be involved together with DDR in the induction of the selective autophagy pathway in aSyn-expressing cells. Our data demonstrating that forcing aSyn-expressing cells to arrest in G0/G1 or abrogating DDR in these cells leads to maintenance of autophagy at homeostatic levels are consistent with this hypothesis.
In summary, our findings point to a model for the toxic effects of aSyn in synucleinopathies that involves the induction of RAS-dependent growth signaling, which inappropriately causes postmitotic cells to re-enter the cell cycle. This is followed by the activation of DDR that triggers autophagy and the inactivation of RNR. This likely causes a reduction in the dNTP pools, which traps cells in S-phase and induces regulated cell death ( Figure 6 ). These findings are remarkably similar to our earlier findings that elevated levels of growth signaling induced by high levels of glucose also lead to inappropriate re-entry of quiescent, stationary-phase budding yeast cells into the cell cycle, and regulated cell death, which is blocked by inactivating Ras2 or by overexpressing RNR1 (Weinberger, Sampaio-Marques, Ludovico, & Burhans, 2013) . The similarities between these phenotypes and cancer suggest the intriguing possibility that some of the molecular events underlying synucleinopathies are caused by chronic hyperglycemia. Indeed, in addition to neoplastic disease (Weinberger et al., 2013), hyperglycemia and/or diabetes are risk factors for some neurodegenerative diseases including synucleinopathies (Ohara et al., 2011) .
Multiple pathways of cellular dysfunction associated with aSyn aggregation have previously been implicated in models of synucleinopathies, including nuclear, mitochondrial, ER/Golgi, and autophagic dysfunction as well as dysfunctional organelle dynamics (Wong & Krainc, 2017) . Although all of these dysfunctional pathways contribute to aSyn cytotoxicity, we consider it likely that many of these pathways converge on the conserved molecular events in postmitotic neurons related to dNTP metabolism that are predicted by our experiments. In this model, autophagy-dependent reduction in levels of RNR activity and levels of dNTPs is the proximate cause of cell death of postmitotic neurons in many patients suffering from synucleinopathies, downstream of cellular dysfunction associated with aSyn aggregation. This provides the opportunity to develop more effective therapeutic strategies for treating these patients by targeting events that directly impact growth signaling and/or dNTP metabolism. Human H4 neuroglioma cells were maintained in Opti-MEM medium (Thermo Fisher) supplemented with 10% fetal bovine serum and incubated at 37°C, 5% CO 2 . Viability was assessed using the CellTiter 96 AQueous One Solution Cell Proliferation Assay (MTS) (Promega) according to the manufacturer's instructions.
| Chronological lifespan assays
Cells were grown on synthetic liquid media until reaching stationary phase, and this time point was considered day 0 of chronological lifespan (CLS). Samples for survival assessment were collected from day 0 of CLS (when viability was considered to be 100%) and then again every 2-3 days until less than 0.01% of the cells in the culture were viable. Mean (50% survival) lifespan and maximum (10% survival) lifespan were determined from curve fitting of the survival data (from pair-matched, pooled experiments) with the statistical software Prism (GraphPad Software). 
| H4 cell transient transfection
| Cell cycle analysis
Cell cycle analysis in yeast cells was performed essentially as previously described (Fortuna et al., 2001) 
| Budding index
The budding status of at least 300 individual yeast cells from each sample was visually determined using an Olympus BX60 microscope.
Cell clumps were dissociated by sonication (Vibra-Cell ™ Ultrasonic
Liquid Processor-VC 130).
| Preparation of protein extracts
Yeast cells were disrupted using glass beads in cold lysis buffer (1% v/v Triton X-100, 120 mM NaCl, 50 mM Tris-HCl pH 7.4, 2 mM After lithium acetate removal, 0.4 M NaOH was added for 5 min on ice, and then, the protocol for protein extraction was followed.
For H4 cells, protein extraction was performed with lysis buffer (1% NP-40, 500 mM Tris-HCL, 2.5 M NaCl, 20 mM EDTA, and phosphatase and protease inhibitors, at pH 7.2). Samples were incubated for 30 min at 4°C with agitation, sonicated in an ultrasonic ice-cold bath for 15 min, and centrifuged at 13,000 rpm during 30 min; the supernatant was considered the total protein extract.
| Western blot
Western blots of protein extracts from both yeast and H4 cells were carried out by resolving 20 μg of the total protein on a 12% SDSpolyacrylamide gel and transferred to a nitrocellulose membrane for 7-15 min in Trans-Blot Turbo Transfer System (Bio-Rad). For Rad53 detection, extracts were overrun in a 7.5% SDS-polyacrylamide gel. Millipore), rabbit anti-Rnr1 (1:5,000; Agrisera), rabbit anti-Rnr3
(1:1,000; Agrisera), rabbit anti-cyclin D1 (1:1,000; Cell Signaling), mouse anti-cyclin E (1:500; Invitrogen), goat anti-actin (1:5,000; from C. Gourlay laboratory), rabbit anti-LC3A/B (1:1,000; Cell Signaling), mouse anti-p62 (1:1,000; Abcam), and mouse anti-alpha-actin
(1:1,000; Millipore) were used. Secondary antibodies (HRP, anti-rabbit, anti-mouse, and anti-goat) were from Bio-Rad (1:5,000 
| Monitoring autophagy by GFP-Atg8 assay
The delivery of Atg8 to the vacuole was followed by the GFP N-terminally tagged to Atg8 (Cheong & Klionsky, 2008) . As GFP is more resistant to the vacuolar degradation than Atg8, bulk autophagy results in the accumulation of free GFP in the vacuole. GFP-Atg8
and free GFP are detectable by Western blotting using a GFP-specific antibody. To perform this assay, cells were transformed with the plasmid pRS416-GFPAtg8 with fusion gene under the control of the ATG8 endogenous promoter. The ratio between free GFP and total GFP is used as a readout for the autophagic flux. Immunoblot bands were quantified by densitometric analysis using the Quantity One software.
| Immunofluorescence staining
H4 cells were resuspended in PBS, 24 hr after transfection, and were fixed with 2% PFA during 15 min at RT. Cells were then washed, permeabilized, and blocked with 4% BSA in PBS 0.05% Tween. Primary antibody, anti-LC3
A/B (1:250), was incubated overnight at 4°C. Anti-Rabbit IgG Alexa Fluor 488 green fluorescent dye (Molecular Probes) was used as secondary antibody.
Nuclei were stained with DAPI (4',6-diamidino-2-phenylindole). An Epifluorescence Microscope (BX61 microscope with an Olympus DP70 camera) was used, and images were analyzed with ImageJ ® software v1.49 (NIH). 
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